Literature DB >> 10826585

Uteroplacental blood flow and placental vascular endothelial growth factor in normotensive and pre-eclamptic pregnancy.

L A Simmons1, A Hennessy, A G Gillin, R W Jeremy.   

Abstract

OBJECTIVE: To determine whether placental vascular endothelial growth factor (VEGF) is increased in pre-eclampsia.
DESIGN: Prospective cohort study.
SETTING: Royal Prince Alfred Hospital, Sydney, Australia. SAMPLE: Eleven normotensive women and eight women with pre-eclampsia matched for age and gestation.
METHODS: Uterine artery Doppler ultrasound flow velocity profiles were recorded in the third trimester and resistance index calculated as (Vs-Vd)/Vs (Vs = peak systolic flow velocity, Vd = end diastolic flow velocity). Placental tissue at delivery was examined for VEGF distribution with avidin-biotin-peroxidase immunohistochemistry.
RESULTS: Uterine resistance index [median (range)] was significantly increased in pre-eclamptic women (normotensive: 0.42 (0.36-0.51); pre-eclampsia: 0.59 (0.40-0.75); P = 0.005). Notching of the uterine artery waveform, consistent with a high resistance circulation, was evident in early diastole in five women with pre-eclampsia but only one normotensive woman (P = 0.013). Placental VEGF was increased in women with pre-eclampsia in the decidual trophoblast (normotensive: 34% (4-59) cells stained for VEGF; pre-eclampsia: 58% (15-95); P = 0.033) and in the villous syncytiotrophoblast (normotensive: VEGF count 1.4 arbitrary units (1.1-2.1); pre-eclampsia: 1.8 arbitrary units (1.4-2.2); P = 0.041). Analysis indicated that uterine artery resistance index was directly correlated with placental VEGF staining, mean arterial pressure and birthweight.
CONCLUSIONS: Abnormal uterine artery Doppler ultrasound flow velocity profiles in pre-eclampsia indicate increased uteroplacental resistance. The associated increase in placental VEGF may represent a compensatory mechanism attempting to restore blood flow towards normal.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10826585     DOI: 10.1111/j.1471-0528.2000.tb13312.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

1.  The influence of tocolytic drugs on cardiac function, large arteries, and resistance vessels.

Authors:  Isabelle G Fabry; Peter De Paepe; Jan G Kips; Luc M Van Bortel
Journal:  Eur J Clin Pharmacol       Date:  2011-04-15       Impact factor: 2.953

2.  Vascular Endothelial Growth Factor Delivery to Placental Basal Plate Promotes Uterine Artery Remodeling in the Primate.

Authors:  Jeffery S Babischkin; Graham W Aberdeen; Jonathan R Lindner; Thomas W Bonagura; Gerald J Pepe; Eugene D Albrecht
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

3.  Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women.

Authors:  Sarah N Cross; Elena Ratner; Thomas J Rutherford; Peter E Schwartz; Errol R Norwitz
Journal:  Rev Obstet Gynecol       Date:  2012

4.  Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension.

Authors:  S D Sykes; K G Pringle; A Zhou; G A Dekker; C T Roberts; E R Lumbers
Journal:  J Hum Hypertens       Date:  2013-06-20       Impact factor: 3.012

Review 5.  Regional anesthesia in patients with pregnancy induced hypertension.

Authors:  Saravanan P Ankichetty; Ki Jinn Chin; Vincent W Chan; Raj Sahajanandan; Hungling Tan; Anju Grewal; Anahi Perlas
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.